Your browser doesn't support javascript.
loading
ETNA-VTE Europe: Benefits and risks of venous thromboembolism treatment using edoxaban in the first 3 months.
Agnelli, Giancarlo; Hoffmann, Ulrich; Hainaut, Philippe; Gaine, Sean; Ay, Cihan; Coppens, Michiel; Schindewolf, Marc; Jimenez, David; Brüggenjürgen, Bernd; Levy, Pierre; Laeis, Petra; Fronk, Eva-Maria; Zierhut, Wolfgang; Malzer, Thomas; Manu, Marius Constantin; Reimitz, Paul-Egbert; Bramlage, Peter; Cohen, Alexander T.
Afiliação
  • Agnelli G; Internal and Cardiovascular Medicine-Stroke Unit, University of Perugia, Perugia, Italy. Electronic address: giancarlo.agnelli@unipg.it.
  • Hoffmann U; Division of Angiology, Medical Clinic IV, University Hospital, Ludwig-Maximilians-University, Munich, Germany. Electronic address: ulrich.hoffmann@med.uni-muenchen.de.
  • Hainaut P; Department of General Internal Medicine, Cliniques Universitaires Saint Luc, UCL, Bruxelles, Belgium. Electronic address: philippe.hainaut@uclouvain.be.
  • Gaine S; National Pulmonary Hypertension Unit, Mater Misericordiae University Hospital, Dublin, Ireland. Electronic address: sgaine@mater.ie.
  • Ay C; Clinical Division of Haematology and Haemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria. Electronic address: cihan.ay@meduniwien.ac.at.
  • Coppens M; Department of Vascular Medicine, Academic Medical Center, Amsterdam, the Netherlands. Electronic address: m.coppens@amc.nl.
  • Schindewolf M; Division of Angiology, Swiss Cardiovascular Center, Inselspital, Bern University Hospital, University of Bern, Switzerland. Electronic address: marc.schindewolf@insel.ch.
  • Jimenez D; Respiratory Department, Ramón y Cajal Hospital, Madrid, Spain.
  • Brüggenjürgen B; Institute for Health Economics, Steinbeis-University, Berlin, Germany. Electronic address: bernd.brueggenjuergen@charite.de.
  • Levy P; LEDa-LEGOS, Université Paris-Dauphine, PSL University, Paris, France. Electronic address: pierre.levy@dauphine.fr.
  • Laeis P; Daiichi Sankyo Europe GmbH, Munich, Germany. Electronic address: petra.laeis@daiichi-sankyo.eu.
  • Fronk EM; Daiichi Sankyo Europe GmbH, Munich, Germany. Electronic address: eva-maria.fronk@daiichi-sankyo.eu.
  • Zierhut W; Daiichi Sankyo Europe GmbH, Munich, Germany. Electronic address: wolfgang.zierhut@daiichi-sankyo.eu.
  • Malzer T; Daiichi Sankyo Europe GmbH, Munich, Germany. Electronic address: thomas.malzer@daiichi-sankyo.eu.
  • Manu MC; Daiichi Sankyo Europe GmbH, Munich, Germany. Electronic address: marius.manu@daiichi-sankyo.eu.
  • Reimitz PE; Daiichi Sankyo Europe GmbH, Munich, Germany. Electronic address: paul-egbert.reimitz@daiichi-sankyo.eu.
  • Bramlage P; Institute for Pharmacology and Preventive Medicine, Berlin, Germany. Electronic address: peter.bramlage@ippmed.de.
  • Cohen AT; Guy's and St Thomas' NHS Foundation Trust, King's College London, United Kingdom. Electronic address: alexander.cohen@kcl.ac.uk.
Thromb Res ; 196: 297-304, 2020 12.
Article em En | MEDLINE | ID: mdl-32950897
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Embolia Pulmonar / Tromboembolia Venosa Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Embolia Pulmonar / Tromboembolia Venosa Idioma: En Ano de publicação: 2020 Tipo de documento: Article